These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8021495)

  • 21. Transforming growth factor-beta enhances human T-cell leukemia virus type I infection.
    Moriuchi M; Moriuchi H
    J Med Virol; 2002 Jul; 67(3):427-30. PubMed ID: 12116037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T lymphotropic virus I infection deregulates surface expression of the transferrin receptor.
    Vidal C; Matsushita S; Colamonici OR; Trepel JB; Mitsuya H; Neckers LM
    J Immunol; 1988 Aug; 141(3):984-8. PubMed ID: 2899599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites.
    Mori N; Ueda A; Ikeda S; Yamasaki Y; Yamada Y; Tomonaga M; Morikawa S; Geleziunas R; Yoshimura T; Yamamoto N
    Cancer Res; 2000 Sep; 60(17):4939-45. PubMed ID: 10987310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms.
    Fox FE; Ford HC; Douglas R; Cherian S; Nowell PC
    Cell Immunol; 1993 Aug; 150(1):45-58. PubMed ID: 8393732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of HTLV-1-infected cell proliferation by a novel tetramethylnaphthalene derivative.
    Hamasaki T; Toyama M; Aoyama H; White Y; Okamoto M; Arima N; Hashimoto Y; Baba M
    Anticancer Res; 2011 Jun; 31(6):2241-7. PubMed ID: 21737647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HTLV-I-induced T-cell activation.
    Buckle GJ; Hafler DA; Höllsberg P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S107-13. PubMed ID: 8797712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta.
    Jones KS; Akel S; Petrow-Sadowski C; Huang Y; Bertolette DC; Ruscetti FW
    J Immunol; 2005 Apr; 174(7):4262-70. PubMed ID: 15778389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition by human T-lymphotropic virus (HTLV-I) of T-lymphocyte mitogenesis: failure of exogenous T-cell growth factor to restore responsiveness to lectin.
    Wainberg MA; Spira B; Boushira M; Margolese RG
    Immunology; 1985 Jan; 54(1):1-7. PubMed ID: 2982729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virus production and spontaneous cell proliferation in HTLV-I-infected lymphocytes.
    Mann DL; Martin P; Hamlin-Green G; Nalewaik R; Blattner W
    Clin Immunol Immunopathol; 1994 Sep; 72(3):312-20. PubMed ID: 8062446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic cross-reactivity between human T lymphotropic virus type I (HTLV-I) and retinal antigens recognized by T cells.
    Fukushima A; Ueno H; Fujimoto S
    Clin Exp Immunol; 1994 Mar; 95(3):459-64. PubMed ID: 8137541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection.
    Kekow J; Wachsman W; McCutchan JA; Cronin M; Carson DA; Lotz M
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8321-5. PubMed ID: 1700428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases.
    Futsch N; Prates G; Mahieux R; Casseb J; Dutartre H
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).
    Ahmadi Ghezeldasht S; Shirdel A; Assarehzadegan MA; Hassannia T; Rahimi H; Miri R; Rezaee SA
    Iran J Basic Med Sci; 2013 Mar; 16(3):179-95. PubMed ID: 24470860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular hallmarks of adult T cell leukemia.
    Yamagishi M; Watanabe T
    Front Microbiol; 2012; 3():334. PubMed ID: 23060864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients.
    Jørgensen PB; Livbjerg AH; Hansen HJ; Petersen T; Höllsberg P
    PLoS One; 2012; 7(9):e46120. PubMed ID: 23049954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator.
    Zhao T; Satou Y; Sugata K; Miyazato P; Green PL; Imamura T; Matsuoka M
    Blood; 2011 Aug; 118(7):1865-76. PubMed ID: 21705495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SCHOOL of nature: IV. Learning from viruses.
    Sigalov AB
    Self Nonself; 2010 Oct; 1(4):282-298. PubMed ID: 21487503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral pathogenesis, modulation of immune receptor signaling and treatment.
    Kim WM; Sigalov AB
    Adv Exp Med Biol; 2008; 640():325-49. PubMed ID: 19065800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.